82 related articles for article (PubMed ID: 2862769)
1. Neuroendocrinological and biochemical effects of chronic neuroleptic treatment.
Hippius H; Ackenheil M; Müller-Spahn F
Adv Biochem Psychopharmacol; 1985; 40():9-13. PubMed ID: 2862769
[No Abstract] [Full Text] [Related]
2. beta-Endorphin, cortisol, and prolactin in serum of schizophrenic patients during long-term neuroleptic treatment and after withdrawal: relationships to psychopathology.
Naber D; Albus M; Muller F; Burke H; Welter D; Ackenheil M; Hippius H
Psychopharmacol Bull; 1982 Oct; 18(4):224-6. PubMed ID: 6130563
[No Abstract] [Full Text] [Related]
3. Effect of long-term neuroleptic treatment on dopamine tuberoinfundibular system: development of tolerance?
Naber D; Fischer H; Ackenheil M
Commun Psychopharmacol; 1979; 3(1):59-65. PubMed ID: 38032
[No Abstract] [Full Text] [Related]
4. Long-term effects of neuroleptic drugs on the neuroendocrine system.
Meltzer HY
Adv Biochem Psychopharmacol; 1985; 40():59-68. PubMed ID: 2862768
[No Abstract] [Full Text] [Related]
5. Basal and stimulated levels of prolactin, TSH, and LH in serum of chronic schizophrenic patients long-term treated with neuroleptics: relations to psychopathology.
Naber D; Ackenheil M; Laakmann G
Adv Biochem Psychopharmacol; 1980; 24():419-23. PubMed ID: 6105792
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic withdrawal in chronic schizophrenia: CT and endocrine variables relating to psychopathology.
Naber D; Albus M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Wissmann J; Ackenheil M
Psychiatry Res; 1985 Nov; 16(3):207-19. PubMed ID: 2868473
[TBL] [Abstract][Full Text] [Related]
7. Diurnal rhythms of plasma cortisol, beta-endorphin and prolactin, and cerebrospinal fluid amine metabolite levels before suicide. Case report.
Dent RR; Ghadirian AM; Kusalic M; Young SN
Neuropsychobiology; 1986; 16(2-3):64-7. PubMed ID: 2438587
[TBL] [Abstract][Full Text] [Related]
8. Clinical assessment of dopamine receptor blockade.
Sedvall G; Bjerkenstedt L; Lindström L; Wode-Helgodt B
Life Sci; 1978 Aug; 23(5):425-9. PubMed ID: 29184
[No Abstract] [Full Text] [Related]
9. Influence of yohimbine on release of anterior pituitary hormones.
Goldberg MR; Jackson RV; Krakau J; Island DP; Robertson D
Life Sci; 1986 Aug; 39(5):395-8. PubMed ID: 3016439
[TBL] [Abstract][Full Text] [Related]
10. [Changes in the CSF levels of monoamine metabolites in 102 chronic schizophrenic patients following probenecid before and after neuroleptic medication].
Chen YF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1984 Oct; 17(5):273-7. PubMed ID: 6085683
[No Abstract] [Full Text] [Related]
11. Down-regulation of central dopamine receptors in schizophrenia.
Zemlan FP; Hitzemann RJ; Hirschowitz J; Garver DL
Am J Psychiatry; 1985 Nov; 142(11):1334-7. PubMed ID: 2865903
[TBL] [Abstract][Full Text] [Related]
12. Plasma levels of beta-endorphin under chronic neuroleptic treatment in schizophrenic patients: failure of naloxone to counteract curative effects of neuroleptic drugs.
Emrich HM; Höllt V; Bergmann M; Kissling W; Schmid W; Zerssen DV; Herz A
Adv Biochem Psychopharmacol; 1980; 22():489-502. PubMed ID: 6104902
[No Abstract] [Full Text] [Related]
13. Effects of apomorphine on blood levels of homovanillic acid, growth hormone and prolactin in medicated schizophrenics and healthy control subjects.
Scheinin M; Syvälahti EK; Hietala J; Huupponen R; Pihlajamäki K; Seppälä OP; Säkö E
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(4):441-9. PubMed ID: 2866563
[TBL] [Abstract][Full Text] [Related]
14. The two-syndrome concept and neuroendocrinology of schizophrenia.
Crow TJ; Ferrier IN; Johnstone EC
Psychiatr Clin North Am; 1986 Mar; 9(1):99-113. PubMed ID: 2870481
[TBL] [Abstract][Full Text] [Related]
15. [Effects of cigarette smoking on endocrine function in man].
Yao M; Narita M; Baba S; Kudo M; Kudo T; Oyama T
Masui; 1985 Aug; 34(8):1105-14. PubMed ID: 2999461
[No Abstract] [Full Text] [Related]
16. Neurochemical studies on tardive dyskinesia. I. Urinary homovanillic acid and plasma prolactin.
Tripodianakis J; Markianos M; Garelis E
Biol Psychiatry; 1983 Mar; 18(3):337-45. PubMed ID: 6132625
[TBL] [Abstract][Full Text] [Related]
17. The relationship between clinical and biochemical changes following neuroleptic treatment in schizophrenia.
Cooper SJ; Leahey W; Liddle J; King DJ
Schizophr Res; 1990; 3(4):261-7. PubMed ID: 1703780
[TBL] [Abstract][Full Text] [Related]
18. [Neuroendocrinology and schizophrenia research].
Müller-Spahn F
Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1991; 64():1-96. PubMed ID: 1682802
[No Abstract] [Full Text] [Related]
19. Dopaminergic mediation of beta-endorphin-induced prolactin secretion.
Van Loon GR; De Souza EB; Shin SH
Neuroendocrinology; 1980 Oct; 31(4):293-6. PubMed ID: 6252497
[TBL] [Abstract][Full Text] [Related]
20. Clinical, biochemical, and hormonal aspects of treatment with Des-tyr1-gamma-endorphin in schizophrenia.
Verhoeven WM; van Ree JM; Westenberg HG; Krul JM; Brouwer GJ; Thijssen JH; de Wied D; van Praag HM; Ceulemans DL; Kahn RS
Psychiatry Res; 1984 Apr; 11(4):329-46. PubMed ID: 6204351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
